Cost-utility of attachment-based compassion therapy (ABCT) for fibromyalgia compared to relaxation: a pilot randomized controlled trial
Peñarrubía-María, María T.
Van Gordon, William
Luciano, Juan V.
AffiliationLondon School of Economics and Political Science
Institut de Recerca Sant Joan de Déu, 08950 Esplugues de Llobregat, Spain
Parc Sanitari Sant Joan de Déu, 08830 St. Boi de Llobregat, Spain
University of Barcelona
University of Oxford
PHC Bartomeu Fabrés Anglada, DAP Baix Llobregat Litoral, Unitat Docent Costa de Ponent, Institut Català de la Salut, 08850 Gavà, Spain
Centre for Biomedical Research in Epidemiology and Public Health, CIBERESP, 28029 Madrid, Spain
Miguel Servet Hospital, Aragon Institute of Health Sciences (I+CS), 50009 Zaragoza, Spain
Primary Care Prevention and Health Promotion Research Network, RedIAPP, 28029 Madrid, Spain
MetadataShow full item record
AbstractA recent study has supported the efficacy of Attachment-Based Compassion Therapy (ABCT) compared to relaxation (REL) for the management of fibromyalgia (FM). The main objective of this paper is to examine the cost-utility of ABCT compared to REL in terms of effects on quality-adjusted life years (QALYs) as well as healthcare costs. Forty-two Spanish patients with FM received 8 weekly group sessions of ABCT or REL. Data collection took place at pre- and 3-month follow-up. Cost-utility of the two treatment groups (ABCT vs. REL) was compared by examining treatment outcomes in terms of QALYs (obtained with the EQ-5D-3L) and healthcare costs (data about service use obtained with the Client Service Receipt Inventory). Data analyses were computed from a completers, ITT, and per protocol approach. Data analysis from the healthcare perspective revealed that those patients receiving ABCT exhibited larger improvements in quality of life than those doing relaxation, while being less costly 3 months after their 8-week treatment program had ended (completers: incremental cost M, 95% CI = €−194.1 (−450.3 to 356.1); incremental effect M, 95% CI = 0.023 QALYs (0.010 to 0.141)). Results were similar using an ITT approach (incremental cost M, 95% CI = €−256.3 (−447.4 to −65.3); incremental effect M, 95% CI = 0.021 QALYs (0.009 to 0.033)). A similar pattern of results were obtained from the per protocol approach. This RCT has contributed to the evidence base of compassion-based interventions and provided useful information about the cost-utility of ABCT for FM patients when compared to relaxation. However, the small sample size and short follow-up period limited the generalizability of the findings
CitationD’Amico, F., Feliu-Soler, A., Montero-Marín, J., Peñarrubía-María, M.T., Navarro-Gil, M., Van Gordon, W., García-Campayo, J. and Luciano, J.V., (2020). ‘Cost-utility of attachment-based compassion therapy (ABCT) for fibromyalgia compared to relaxation: a pilot randomized controlled trial’. Journal of Clinical Medicine, 9(3), pp. 1-14.
JournalJournal of Clinical Medicine
The following license files are associated with this item:
- Creative Commons